NAVIGATING THE EVIDENCE FOR EXTRAFINE TRIPLE FORMULATION IN COPD

Thursday, 11 November 2021, 17:00 - 18:00 (Japan Time, UTC+9)


Dr John Blakey (Australia)

Sponsors: ChiesiOrient EuroPharma

Post-webinar video is available until 31 March 2022. (APSR members only)

shutterstock_1385338208.jpg
 

​OUTLINE

This webinar provides a space for respiratory health professionals from around the globe to share their experiences. Participants have the chance to ask questions, discuss, and hear perspectives from the speaker.

FORMAT

  1. Welcome message from the APSR President

  2. Welcome message from the Sponsor

  3. Presentation

  4. Q&As

  5. Summary and Closing

(total: 60 minutes)

TOPICS

​"Navigating the evidence for extrafine triple formulation in COPD" - Dr John Blakey (Australia)

 

SPEAKERS

nakanishi-yoichi-large_edited_edited_edi

Dr Yoichi Nakanishi

President of the APSR

WELCOME MESSAGE

rhee-chin-kook-large.jpg

Dr. Chin Kook Rhee


Head-Elect of APSR COPD Assembly

CHAIR

James.jpg

Dr James Micevski

Medical Director of CHIESI, Australia

SPONSOR REPRESENTATIVE

John Blakey headshot.jpg

Dr John Blakey (Australia)

Respiratory Physician Consultant and lead for Asthma at Sir Charles Gairdner Hospital, Perth WA. Adjunct Clinical Associate Professor at Curtin Medical School in Perth, WA.

SPEAKER

 

SPONSORS

The APSR would like to thank our sponsors for their contribution to the APSR Educational Webinars.

Chiesi Logo - 1.Primary.png
OEP company logo_edited.jpg